(B) | 1. |
ÀVÀR¯ß«ã±i¤§¯fºA¡A¥i¦b¦óºØ¯e¯f¥X²{¡G
(1) ¤T¦y䳬Âꤣ¥þ¡C
(2) ¤ßÁY©Ê¤ß¥]½¤ª¢¡]constrictive pericarditis¡^¡C
(3) ¥D°Ê¯ß䳬Âꤣ¥þ¡C
(4) ÂX¤j©Ê¤ß¦Ù¯g¡C
|
A. | 1+2+3 |
B. | 1+2+4 |
C. | 1+3 |
D. | 1+3+4 |
E. | 2+3+4 |
|
(C) | 2. |
¨Ï¥Î«D«I¥Ç©Ê©I§lªvÀø¡]Noninvasive ventilation¡^ªº¾AÀ³¯g¡A¤U¦C¦óªÌ°£¥~¡H
|
A. | °Ê¯ß¦åpH > 7.22¡C |
B. | ¤ßŦ´`Àô¥\¯àéw¡C |
C. | ©I§l¹D¤Àªcª«¹L¦h¡C |
D. | µL¤W©I§l¹Dªý¶ë¯fÅÜ¡C |
E. | ¯«´¼²M·¡¡B¦X§@ªº¯f¤H¡C |
|
(D) | 3. |
¦³Ãö¶Ý»Ì²ÓM½F¤§±Ôz¡A¦óªÌ¦³»~¡H
(1) §¿catecholamine¤§´ú©w¤ñmetanephrine¡BVMA´ú©w¶EÂ_²v°ª¡C
(2) paroxysmal°ª¦åÀ£¤ñ«ùÄò©Ê°ª¦åÀ£±`¨£¡C
(3) ³N«á§C¦åÀ£¥i¥Î£\-ªýÂ_¾¯©ó³N«e¨Ï¥Î¨Ó¹w¨¾¡C
(4) ©óMEN¯gÔ¸s®É¡AÀ³¥ý¤Á°£¶Ý»Ì²ÓM½F¡C
(5) ²Ó°w¬ï¨ë²ÓM¾Ç¥i¥Î¨ÓŲ§O¶EÂ_¡C
|
A. | 1+3 |
B. | 2+4 |
C. | 3+5 |
D. | 2+5 |
E. | 1+4 |
|
(D) | 4. |
¥þ¨©Ê¬õ´³©Ê¯T½H(SLE)®É¡A¦³¦óºØ²Õ¦X¡A»Ýn°ª¾¯¶qÃþ©T¾J©Î¨ä¥L±j¤OªºªvÀø¡H
|
A. | Fever and arthritis |
B. | Pleurisy and Raynaud's phenomenon |
C. | Peripheral neuropathy and skin vasculitis |
D. | Central nervous system disease and hemolytic anemia (marked) |
E. | Skin vasculitis and splenomegaly |
|
(A) | 5. |
¹ï©ó¹¹DÀR¯ß¦±±i¥X¦åªº±wªÌ¡A¤U¦C¦UºØªvÀø¤è¦¡¡A¦óªÌ¿ù»~¡H
|
A. | «æ©Ê¥X¦å®É¡A¥i¦Ò¼{¨Ï¥ÎH2-receptor blocker¡C |
B. | «æ©Ê¥X¦å®É¡A¥i¦Ò¼{¨Ï¥ÎVasopressin©Î¨äl¥Íª«¡C |
C. | «æ©Ê¥X¦å®É¡A¥i¦Ò¼{¬I¥HEndoscopic sclerotherapy©Îligation¡C |
D. | ±¡ªpéw«á¡A¥i¦Ò¼{¨Ï¥Îpropranololµ¥«D¿ï¾Ü©Ê£]-adrenergic blocker¨Ó¹w¨¾¨ä¦A¥X¦å¡C |
E. | ¤@¦A¥X¦åªÌ¡A¥i¦Ò¼{¨Ï¥ÎTIPS¡]Transjugular Intrahepatic Portosystemic Shunting¡A¤@ºØ¥´³q¨xÀR¯ß©M¨xªù¯ß¤§§Þ³N¡^¡C |
|
(B) | 6. |
¤U¦C¨º¤@Ó°ò¦](gene)»P²ÓMä¤`(apoptosis)¦³Ãö¡H
|
A. | Bcl-1 |
B. | Bcl-2 |
C. | Bcl-6 |
D. | c-myc |
E. | ras-gene |
|
(D) | 7. |
¤U¦C¦³Ãö¨ÅÁÞúC¯Ê¥F¯g¡]lactase deficiency¡^¤§±Ôz¡A¦óªÌ¥¿½T¡H
(1) ±wªÌÁT«K¤§pHȱ`¸û§C
(2) ¯gª¬±`¶}©l©ó¥®¦~´Á
(3) ¥Õ¤H¤§¿©±w²v¤Ö©ó¶Â¤H¤ÎªF¤è¤H
(4) ¨ÅÁÞ©I§l²B§t¶q´ú©w¦³§U¶EÂ_
(5) ¹ïÀu¹T¨Å¡]yogurt¡^¥ç¤£¯à§Ô¨ü
|
A. | 1+2+3+4 |
B. | 2+3+4+5 |
C. | 1+3+4+5 |
D. | 1+3+4 |
E. | 2+3+4 |
|
(B) | 8. |
¥Ö½§¤W§e²{·L¦åºÞÂX±i(telangiectasia)¡A±`»P¨ä¥¦¯e¯f¦³Ãö¡A¦pªG¬O¦b«ü¥Ò©P³ò¡A«h¤U¦C¦óªÌ¥¿½T¡H
(1) Cirrhosis(¨xµw¤Æ)
(2) Dermatomyositis(¥Ö¦Ùª¢)
(3) Lupus erythematosus(¬õ´³©Ê¯T½H)
(4) Scleroderma(µw¥Ö¯g)
(5) Tuberculoid leprosy(µ²®Ö«¬³ÂºÆ)
|
A. | 1+2+5 |
B. | 2+3+4 |
C. | 3+4 |
D. | 2+3+5 |
E. | 1+5 |
|
(D) | 9. |
ºë¯«¯«¸g§K¬Ì¾Ç¡]Psychoneuroimmunology¡^¬O¬ã¨sÀ£¤O»P§K¬ÌÃö«Yªº·s¿³¬ì¾Ç¡Aºî¦X¹L¥hªº¬ã¨sµo²{¡A¤U¦C¨º¶µ±Ôz¬°¥¿½T¡H
|
A. | §K¬Ì¥\¯à¤£¨ü¶Ê¯v¼vÅT |
B. | ²O¤Ú²y¤£·|¤Àªc¯«¸g¶Ç¾Éª«½è¡]neurotransmitters¡^ |
C. | ¥Íªø¿E¯À¡]growth hormone¡^¤£·|¼vÅT§K¬Ì¤O |
D. | ³z¹L¨î¬ù¡]conditioning¡^¥i¼vÅT§K¬Ì¨t²Î¥\¯à |
E. | ÃĪ«ÀݥΦp°sºë»P¥§¥j¤B¨Ã¤£·|¼vÅT§K¬Ì¨t²Î¥\¯à |
|
(D) | 10. |
¤@¦ì66·³¨k©Ê¯f¤HÁy³¡¡BÀV³¡¤ÎI³¡¦³¬õ´³¡A¦h¼ÆÃö¸`»Äµh¡A¥|ªÏªºªñºÝ¦Ù¦×µL¤O¡A¦³¤G¬P´Á¤§¤[¡C¸g©â¦åÀˬdµo²{CPK (MM type)¡AGPT¤Îaldolase§¡¦³©úÅã¼W¥[¡A¶EÂ_¬°dermatomyositis¡C¸Õ°Ý³oÓ¯f¤HÁÙ¥²¶·±µ¨ü¨ÇÀˬd¡H
|
A. | ¥Ö½§ªº¯f²zÀˬd |
B. | ¦Ù¦×¤Î¯«¸g¾ÇÀˬd |
C. | §K¬Ì¦å²M¾ÇÀˬd |
D. | ¸~½Fªº¿zÀË |
E. | ¤ßªÍ¥\¯àªºÀˬd |
|
(B) | 11. |
¦³¤@40·³¨k©Ê³ÌªñÅ髼W¥[¡]5¤½¤ç/2¤ë¡^¡A¤â¦³³Â¤ì·P¡A®É±`·Pı«å¡B¦h¦½¡A²z¾ÇÀˬd²{BP 146/94 mmHg¡APR 72/min¡Aregular¡AÁy³¡ªo¥ú¡A¦³carpal tunnel syndrome¡A¸g¸ß°Ý¯f¤Hµo²{¾c¤l¸¹¼ÆÅܤj¡C¿ï¤@³Ì¾A·í¤§µª®×¡G
|
A. | ¯f¤H¦³dysmetabolic syndrome X |
B. | ¯f¤Hªº¤â³Â¤ì¬O¦]ªÏºÝ³n²Õ´À£¢©ÒP |
C. | °ò¦¥Íªø¿E¯À´ú©w¥iŲ§O¶EÂ_ |
D. | µ¹¤©¯f¤HL-Dopa¡A¥Íªø¿E¯À¦å¼ß¿@«×À³¤É°ª |
E. | Octreotide (Sandostatin)ªºªvÀø§K°£¤Ftrans-sphenoid surgery |
|
(D) | 12. |
¦³ÃöºKµÊ¡]splenectomy¡^¡A¤U¦C¨º¤@¶µ±Ôz¬O¿ù»~ªº¡H
|
A. | ¥Î©óªvÀø¥ý¤Ñ©Ê²yª¬¬õ¦å²y¯g¡]congenital spherocytosis¡^ |
B. | ¥Î©óªvÀøµÊ¤®¶i¡]hypersplenism¡^©Ò¾ÉP¤§¦å²y´î¤Ö¯g¡]cytopenia¡^ |
C. | ¥Î©óªvÀø¾vª¬²ÓM©Ê¥Õ¦å¯g¡]hairy cell leukemia¡^ |
D. | ºKµÊ«á¡A±`¨£WBC¼Æ¼W¥[¡A¦ý¬õ¦å²y§ÎºA«h¨S¦³ÅÜ¤Æ |
E. | 20·³¥H¤U±wªÌ¡AºKµÊ«á¡A¸û©ö¦³ÄY«²Óµß·P¬V |
|